2018•European Journal of Nuclear Medicine and Molecular ImagingRequires access

Targeting PSMA by radioligands in non-prostate disease—current status and future perspectives

Philipp Backhaus, Benjamin Noto, Nemanja Avramović, Lena Sophie Grubert, Sebastian Huss, Martin Bögemann, Lars Stegger, Matthias Weckesser, Michael Andreas Schäfers, Kambiz Rahbar

Open publisher page 143 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 143 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Prostate cancer, Medicine, Prostate, Glutamate carboxypeptidase II, PCA3, Disease, Cancer research, Pathology

Back to paper search Browse research topics Original source

Targeting PSMA by radioligands in non-prostate disease—current status and future perspectives — Research Paper | ScholarLens